According to Marinus Pharmaceuticals's latest financial reports and stock price the company's current number of shares outstanding is 53,920,109. At the end of 2023 the company had 53,920,109 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Year | Shares Outstanding | Change |
---|---|---|
2023 | 53.92 M | 19.89% |
2022 | 44.97 M | 22.39% |
2021 | 36.74 M | 15.43% |
2020 | 31.83 M |
Company | Shares Outstanding | differencediff. | Country |
---|---|---|---|
Supernus Pharmaceuticals
SUPN | 54,608,963 | 1.28% | ๐บ๐ธ USA |
Endo International
ENDPQ | 235,220,000 | 336.24% | ๐ฎ๐ช Ireland |
AcelRx Pharmaceuticals
ACRX | 16,758,322 | -68.92% | ๐บ๐ธ USA |
Eagle Pharmaceuticals
EGRX | 13,090,852 | -75.72% | ๐บ๐ธ USA |